Sanofi Goodwill and Intangible Assets 2010-2024 | SNY

Sanofi goodwill and intangible assets for the quarter ending June 30, 2024 were $82.634B, a 2.64% increase year-over-year.

  • Sanofi goodwill and intangible assets for 2023 were $79.79B, a 5.87% increase from 2022.
  • Sanofi goodwill and intangible assets for 2022 were $75.366B, a 8.29% decline from 2021.
  • Sanofi goodwill and intangible assets for 2021 were $82.182B, a 14.59% increase from 2020.

Sanofi Goodwill and Intangible Assets 2010-2024 | SNY

  • Sanofi goodwill and intangible assets for 2023 were $79.79B, a 5.87% increase from 2022.
  • Sanofi goodwill and intangible assets for 2022 were $75.366B, a 8.29% decline from 2021.
  • Sanofi goodwill and intangible assets for 2021 were $82.182B, a 14.59% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Innoviva (INVA)$953M